Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Theranostic Applications of Nanomaterials

Author(s): Keerti Jain and Jian Zhong

Volume 28, Issue 2, 2022

Page: [77 - 77] Pages: 1

DOI: 10.2174/138161282802211223150153

« Previous Next »
[1]
Parashar P, Singh N. Alka, Maurya P, Saraf SA. An assessment of in vitro and in vivo evaluation methods for theranostics nanomaterials. Curr Pharm Des 2022; 28(2): 78-90.
[2]
Sahoo RK, Singh H, Thakur K, Gupta U, Goyal AK. Theranostic applications of nanomaterials in the field of cardiovascular diseases. Curr Pharm Des 2022; 28(2): 91-103.
[3]
Morsink M, Parente L, Silva F, et al. Nanotherapeutics and nanotheragnostics for cancers: properties, pharmacokinetics, biopharmaceutics, and biosafety. Curr Pharm Des 2022; 28(2): 104-15.
[4]
Tripathi P, Shukla P, Bieberich E. Theranostic applications of nanomaterials in alzheimer’s disease: A multifunctional approach. Curr Pharm Des 2022; 28(2): 91-103.
[5]
Ahmed F, Khan MA, Haider N, Ahmad MZ, Ahmad J. Recent advances in theranostic applications of nanomaterials in cancer. Curr Pharm Des 2022; 28(2): 133-50.
[6]
Wang X, Zheng M, Raza F, et al. Recent developments in mesoporous silica nanoparticles for tumor theranostic applications. Curr Pharm Des 2022; 28(2): 151-64.
[7]
Paliwal R, Kumar P, Chaurasiya A, Kenwat R, Katke S, Paliwal SR. Development of nanomedicines and nano-similars: Recent advances in regulatory landscape. Curr Pharm Des 2022; 28(2): 165-77.

Rights & Permissions Print Cite
Article Metrics
18
1
© 2024 Bentham Science Publishers | Privacy Policy